Rafael Rosell, MD PhD
Chief Scientific Officer, Chairman,
Co-Founder


Rafael Rosell, MD, PhD, is also founder of the Spanish Lung Cancer Group, President and Director of the Cancer Biology and Precision Medicine Program at the Catalan Institute of Oncology (ICO). Dr Rosell’s contributions to translational medical oncology, with particular emphasis on the field of non-small-cell lung cancer with EGFR mutations, have earned him international recognition: in 2013 he was recognized by The Lancet as the highest authority in lung cancer in Europe, and he has received numerous awards in recognition of his tireless investigations into the causes and treatment of cancer.


We use first and third party cookies to track your browsing habits on our website in order to provide you with better quality and security, and improve the services offered through this website. If users do not explicitly confirm that they consent to the installation of cookies but continue to browse our website, we will assume that they have agreed and we will inform them accordingly about the possibility of blocking or deleting any previously installed cookies by adjusting their browser settings. You can find out more about cookies in our "Cookie Policy".

COOKIE POLICY